Norovirus could be on its way into your home as you read this. It’s having an earlier-than-usual surge this winter, likely due to the rise of a new and potentially more infectious variant, GII.17. If ...

Fig. 1. Synthesis and characterization of KfAQ and KfAQ-Pd. This work not only presents a new pathway to reduce the energy barrier for hydrogen extraction from water molecules but also offers valuable ...

BP has cancelled the development of its Duqm Green Hydrogen Project in Oman, the UK supermajor has told Upstream's sister title Hydrogen Insight. The decision “is line with BP’s global strategy to ...

BP Plc is abandoning plans to proceed with its big Teesside hydrogen plant in England’s northeast, after the project clashed with a proposal for a large data center on the same site. A planning ...

At low temperatures, hydrogen atoms move less like particles and more like waves. This characteristic enables quantum tunneling, the passage of an atom through a barrier with a higher potential energy ...

Written by: Anupam Agarwal, M.D. The past month saw the culmination of years of planning and construction with the official openings of the Altec/Styslinger Genomic Medicine and Data Sciences Building ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

In a bulletin on Friday, GM announced that it will end its HYDROTEC brand's work on hydrogen fuel cell development. Instead, GM will focus its R&D efforts on batteries, charging technologies and ...

Oct 6 (Reuters) - Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca (AZN.L), opens new tab a license to develop therapies the U.S.-based biotech discover using its AI-driven gene ...

FILE PHOTO: Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) -Algen Biotechnologies said on ...

Oct 6 (Reuters) - AstraZeneca (AZN.L), opens new tab has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The ...

(Reuters) -Algen Biotechnologies said on Monday it had agreed to grant AstraZeneca a license to develop therapies the U.S.-based biotech discover using its AI-driven gene-editing platform, in a deal ...